UP

US approves new drug to treat Alzheimer's disease

Home page Science
12 Punto 14 Punto 16 Punto 18 Punto
US approves new drug to treat Alzheimer's disease

The US Food and Drug Administration on Friday approved a highly anticipated new drug designed to slow cognitive decline in patients in mild and early stages of Alzheimer's disease.

Axar.az reports the FDA approval of the drug, Leqembi, also known as lecanemab, comes just days after the regulatory agency was harshly criticised in a congressional report for its green-lighting of another Alzheimer's drug, Aduhelm.

And it was granted despite trial results showing the monoclonal antibody treatment carries risks of brain swelling and bleeding.

Both drugs were approved through an accelerated process that allows the FDA to fast-track approval of drugs for serious conditions where there is an unmet medical need.

Date
2023.01.07 / 11:38
Author
Axar.az
See also

Aliyev releases video summarizing Vietnam visit - Video

Trump praises Melania's role in Ukraine-Russia efforts

Austrian foreign ministry website hacked

Tahir Abdullayev secures another UFC victory

Paolo Bulgari passes away at the age of 89

Galatasaray beat Samsunspor to maintain Super Lig lead

President Ilham Aliyev concluded his visit to Vietnam

Trump says agreement with Iran should be permanent

US aims to hold trilateral peace talks before December 25

MIT chief holds talks with Hamas political leader

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla